Jürgen Finke Selected Research

Therapeutics

1/2024	Allogeneic haematopoietic cell transplantation for therapy-related myeloid neoplasms arising following treatment for lymphoma: a retrospective study on behalf of the Chronic Malignancies Working Party of the EBMT.
7/2023	Upper and/or Lower Respiratory Tract Infection Caused by Human Metapneumovirus After Allogeneic Hematopoietic Stem Cell Transplantation.
4/2023	Primary Cancer Matters in Therapy-related Myeloid Neoplasm Patients Receiving Allogeneic Hematopoietic Cell Transplantation: A Study From the Chronic Malignancies Working Party of the EBMT.
12/2022	Long-Term Results of Allogeneic Stem Cell Transplantation in Adult Ph- Negative High-Risk Acute Lymphoblastic Leukemia.
1/2022	Allogeneic hematopoietic cell transplantation in patients with therapy-related myeloid neoplasm after breast cancer: a study of the Chronic Malignancies Working Party of the EBMT.
12/2021	Allogeneic Stem Cell Transplantation in Multiple Myeloma.
12/2021	Impact of prior JAK-inhibitor therapy with ruxolitinib on outcome after allogeneic hematopoietic stem cell transplantation for myelofibrosis: a study of the CMWP of EBMT.
11/2021	The impact of pulmonary function in patients undergoing autologous stem cell transplantation.
1/2020	Transplant outcomes for patients with therapy-related acute myeloid leukemia with prior lymphoid malignancy: an ALWP of EBMT study.
11/2019	Comparable Long-Term Outcome after Allogeneic Stem Cell Transplantation from Sibling and Matched Unrelated Donors in Patients with Acute Myeloid Leukemia Older Than 50 Years: A Report on Behalf of the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jürgen Finke Research Topics

Disease

52	Neoplasms (Cancer) 05/2024 - 09/2002
49	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 05/2024 - 01/2007
44	Leukemia 03/2024 - 11/2004
42	Graft vs Host Disease (Graft-Versus-Host Disease) 12/2023 - 02/2003
24	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 01/2024 - 06/2002
23	Lymphoma (Lymphomas) 01/2024 - 06/2003
11	Primary Myelofibrosis (Myelosclerosis) 02/2024 - 10/2016
11	Multiple Myeloma 01/2024 - 02/2006
11	Hematologic Neoplasms (Hematological Malignancy) 01/2023 - 09/2002
11	Bronchiolitis Obliterans Syndrome 10/2022 - 03/2009
10	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 03/2024 - 02/2007
6	Infections 07/2023 - 02/2002
5	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 01/2019 - 08/2002
4	Neutropenia 07/2023 - 02/2002
4	B-Cell Lymphoma (Lymphoma, B Cell) 01/2023 - 09/2003
4	Residual Neoplasm 10/2020 - 06/2005
3	Idiopathic Thrombocytopenic Purpura (Thrombocytopenic Purpura, Autoimmune) 01/2023 - 07/2007
3	Pathologic Complete Response 07/2022 - 02/2012
3	Chronic Myelomonocytic Leukemia (Leukemia, Chronic Myelomonocytic) 01/2022 - 01/2017
3	Cytopenia 01/2020 - 10/2016
3	Chromosome Aberrations (Chromosome Abnormalities) 01/2020 - 06/2012
3	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 10/2019 - 11/2006
3	Mantle-Cell Lymphoma (Lymphoma, Mantle Cell) 01/2019 - 08/2016
3	Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular) 06/2018 - 06/2003
3	Myeloid Leukemia (Leukemia, Myelocytic) 06/2012 - 04/2003
2	COVID-19 01/2023 - 10/2022
2	Blast Crisis (Blast Phase) 01/2023 - 10/2019
2	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 01/2023 - 12/2021
2	Essential Thrombocythemia 11/2020 - 01/2019
2	Polycythemia Vera 11/2020 - 01/2019
2	Hematologic Diseases (Blood Diseases) 10/2019 - 01/2019
2	Virus Diseases (Viral Diseases) 02/2015 - 08/2005
2	Refractory Anemia 10/2014 - 06/2012
2	Thrombocytopenia (Thrombopenia) 07/2007 - 02/2002
2	Disease Progression 08/2006 - 08/2005
1	Obesity 12/2023
1	Heart Diseases (Heart Disease) 10/2023
1	Respiratory Tract Infections (Respiratory Tract Infection) 07/2023
1	Lymphopenia (Lymphocytopenia) 07/2023
1	Brain Neoplasms (Brain Tumor) 01/2023

Drug/Important Bio-Agent (IBA)

12	Methotrexate (Mexate)FDA LinkGeneric 02/2019 - 04/2003
10	fludarabineIBA 12/2023 - 09/2002
9	Carmustine (FIVB)FDA Link 12/2023 - 09/2002
8	Melphalan (Alkeran)FDA LinkGeneric 01/2024 - 09/2002
8	Thiotepa (Triethylenethiophosphoramide)FDA LinkGeneric 12/2023 - 08/2006
8	Cyclosporine (Ciclosporin)FDA LinkGeneric 10/2022 - 04/2003
7	Thomsen-Friedenreich antibodiesIBA 01/2020 - 02/2003
7	GlobulinsIBA 01/2020 - 02/2003
6	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2024 - 09/2015
5	Cytarabine (Cytosar-U)FDA LinkGeneric 11/2017 - 08/2006
4	Busulfan (Busulfex)FDA Link 10/2023 - 09/2015
4	treosulfanIBA 10/2023 - 01/2020
4	Proteins (Proteins, Gene)FDA Link 01/2023 - 04/2006
4	Cell-Free Nucleic AcidsIBA 07/2022 - 02/2018
4	Immunoglobulins (Immunoglobulin)IBA 01/2020 - 08/2005
4	Tyrosine Kinase InhibitorsIBA 10/2019 - 09/2014
4	Rituximab (Mabthera)FDA Link 11/2017 - 05/2016
3	Inosine Triphosphate (ITP)IBA 01/2023 - 07/2007
3	ruxolitinibIBA 12/2021 - 11/2018
3	AntigensIBA 01/2021 - 02/2003
3	Sorafenib (BAY 43-9006)FDA Link 10/2020 - 01/2018
3	Antilymphocyte Serum (Anti-Thymocyte Globulin)IBA 01/2020 - 01/2016
3	HLA Antigens (Human Leukocyte Antigens)IBA 03/2015 - 08/2006
3	Alemtuzumab (Campath)FDA Link 10/2013 - 08/2009
2	Bortezomib (Velcade)FDA Link 01/2024 - 11/2012
2	daratumumabIBA 01/2023 - 01/2022
2	Antiviral Agents (Antivirals)IBA 01/2023 - 02/2002
2	Messenger RNA (mRNA)IBA 01/2023 - 10/2022
2	Mycophenolic Acid (Cellcept)FDA LinkGeneric 08/2021 - 04/2003
2	ibrutinibIBA 01/2020 - 01/2019
2	SteroidsIBA 11/2018 - 08/2009
2	Interleukin-15 (Interleukin 15)IBA 04/2018 - 01/2018
2	Azacitidine (5 Azacytidine)FDA Link 01/2018 - 09/2012
2	CytokinesIBA 06/2014 - 09/2004
2	Granzymes (Granzyme)IBA 12/2013 - 09/2008
2	Monoclonal AntibodiesIBA 10/2013 - 11/2012
2	HLA-DQB1 antigen (HLA DQB1)IBA 11/2012 - 02/2003
2	HLA-DRB1 Chains (HLA DRB1)IBA 11/2012 - 02/2003
2	HLA-B Antigens (HLA-B)IBA 11/2012 - 02/2003
2	HLA-A Antigens (HLA-A)IBA 11/2012 - 02/2003
2	Lenalidomide (CC 5013)FDA Link 09/2012 - 02/2012
2	Budesonide (Pulmicort)FDA LinkGeneric 01/2012 - 03/2009
2	Interleukin-8 (Interleukin 8)IBA 10/2004 - 09/2004
1	Hypoglycemic Agents (Hypoglycemics)IBA 12/2023
1	Insulin (Novolin)FDA Link 12/2023
1	Hemoglobins (Hemoglobin)IBA 10/2023
1	Ribavirin (Virazole)FDA LinkGeneric 07/2023
1	Adrenal Cortex Hormones (Corticosteroids)IBA 07/2023

Therapy/Procedure

69	Stem Cell Transplantation 05/2024 - 02/2002
66	Cell Transplantation 02/2024 - 05/2005
52	Transplantation 05/2024 - 06/2002
44	Hematopoietic Stem Cell Transplantation 03/2024 - 04/2003
25	Therapeutics 01/2024 - 02/2002
13	Homologous Transplantation 10/2023 - 09/2002
11	Drug Therapy (Chemotherapy) 03/2024 - 03/2006
6	Radiotherapy 11/2017 - 06/2003
5	Peripheral Blood Stem Cell Transplantation (Peripheral Stem Cell Transplantation) 01/2016 - 09/2002
3	Bone Marrow Transplantation (Transplantation, Bone Marrow) 01/2022 - 01/2018
2	Immunotherapy 11/2012 - 01/2007
2	Induction Chemotherapy 09/2008 - 01/2008